Meridian Bioscience completes acquisition of Exalenz Bioscience

Meridian Bioscience, Inc. completed its acquisition of Exalenz Bioscience Ltd., an Israeli provider of BreathID urea breath test systems for H. pylori detection.

“We are excited to complete the acquisition of Exalenz Bioscience Ltd. and its H. pylori urea breath testing systems.”biospace.com

• 1 source
• biospace.comMeridian Bioscience Announces Closing of Transaction to Acquire Exalenz Bioscience - BioSpaceAnnalee ArmstrongApr 30, 2020

Summarized from public sources; check the original articles before acting on it.